DAFTAR PUSTAKA

1. Tehupeiory ES. Artritis Gout. Dalam: Edisi V Jilid III Buku Ajar Ilmu Penyakit
Dalam. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FK UI. 2009.
2. So A. Developments in the scientific and clinical understanding of gout. Arthritis Res
Ther, Vol. 10, No 5. 2008. PP.221-27, ISSN 1478-6362.
3. Diana I, Jalal MD, Chonchol M, MD, et al. Uric Acid as a Target of Therapy in CKD.
Am J Kidney Dis. 2013;61(1):134-146.
4. Liu B, Wang T, HN Zhao, et al. The prevalence of hyperuricemia in China: a meta-
analysis. China: BMC Public Health 2011, 11:832.
5. Purwaningsih T. Faktor-Faktor Risiko Hiperurisemia. Program Studi Magister
Epidemiologi. Semarang: Universitas Diponegoro. 2009.
6. Preitner F, Bonny O, Laverrie A, et al. Glut9 is a major regulator of urate homeostasis
and its genetic inactivation induces hyperuricosuria and urate nephropathy.
Switzerland: PNAS University of Lausanne, Lausanne. 2009.
7. Causes and Consequences of Chronic Kidney Disease: Implications for Managed
Health Care Daniel E. Weiner, MD, MS
8. Avram Z & Krishnan N. Hyperuricaemia-When Rheumatology meets Nephrology.
Oxford Journal Rheumatology. 2008;47:960964.
9. Convento MS, Pessoa E, Dalboni MA, Borges FT, Schor N. (2011). Pro-inflammatory
and oxidative effects of noncrystalline uric acid in human mesangial cells:
contributionto hyperuricemic glomerular damage. Urological Research, Vol. 39, No.1,
(June 2010), pp.21-27, ISSN 0300-5623
10. Kutzing, MK & Firestein, BL. (2008). Altered uric acid levels and disease states.
Journal of Pharmacology and Experimental Therapeutics, Vol. 324, No 1, (September
2008), pp.1-7, ISSN 0022-3565.
11. Sanaz S. Serum Uric Acid and Chronic Kidney Disease: The Role of Hypertension.
2010.
12. Shan Y, Zhang Q, Liu Z, Hu X, Liu D. (2010). Prevalence and risk factors associated
with chronic kidney disease in adults over 40 years: a population study from Central
China. Nephrology, Vol. 15, No 3, (April 2010), pp.354-61, ISSN 1440-1797
13. Prevalence of Anemia in Chronic Kidney Disease in the United States Melissa E.
Stauffer1*, Tao Fan2 1SCRIBCO, Effort, Pennsylvania, United States of America,
2Merck & Co., Inc., Whitehouse Station, New Jersey, United States of Ameri
14. Hypertension in Chronic KidneyDisease: Navigating the Evidence F. M. Tedla,1 A.
Brar,1 R. Browne,1 and C. Brown1, 2
15. Albertoni G, Maquigussa E, Pessoa E, Barreto JA, Borges F, Schor N. (2010). Soluble
uric acid increases intracellular calcium through an angiotensin II-dependent
mechanism in immortalized human mesangial cells. Experimetal Biological Medicine,
Vol. 235, No.7, (July 2010), pp.825-832, ISSN 1535-3702.
16. Tom GR & Kelsey MJ. The modern management of gout. Rheumatology. UK:Oxford
University Press on behalf of the British Society for Rheumatology. 2010.
17. Roddy E, Zang W, Doherty M. Concordance of the management of chronic gout in a
UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis
2007;66:13115. 11
18. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med
2005;143:499516.
19. MANDELL BF. Clinical manifestations of hyperuricemia and gout. Department of
Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research,
Cleveland Clinic. CLEVELAND CLINIC JOURNAL OF MEDICINE. 2008. VOL.75.
20. MANDELL BF. Clinical manifestations of hyperuricemia and gout. Department of
Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research,
Cleveland Clinic. CLEVELAND CLINIC JOURNAL OF MEDICINE. 2008. VOL.75.
21. Lisa KS & Peter TC. Gout and its comorbidities: implications for therapy.
Rheumatology. UK:Oxford University Press on behalf of the British Society for
Rheumatology. 2014.
22. Tohidi M, Hasheminia M, Mohebi R, et al. Incidence of Chronic Kidney Disease and
Its Risk Factors, Results of Over 10 Year Follow Up in an Iranian Cohort. USA: PLOS
ONE. 2012. Vol 7(9).
23. Levin A. Identifications of patients and risk factors in chronic kidney disease-
evaluating risk factor and therapeutic strategies. Canada: Nephrol Dial Transplant.
2001.
24. Sijpkens YW. Chronic kidney disease in patients with diabetes mellitus type 2 or
hypertension in general practice. British Journal of General Practice. 2010.
25. ROBIN K. DORE, MD Clinical Professor of Medicine, Division of Rheumatology,
David Geffen School of Medicine, University of California at Los Angeles, Los
Angeles, CA The gout diagnosis Staging of Chronic Kidney Disease: Time for a
Course Correction Carolyn Bauer, Michal L. Melamed, and Thomas H. Hostetter
26. Salem MM. Pathophysiology of hypertension in renal failure. PubMed. 2002. (1)17-
26.
27. Nurko s. Anemia in chronic kidney disease: causes, diagnosis, treatment. Clinic
department of nephrology and hypertension. Cleveland clinic journal of medicine.
2006 (73).
28. Babitt JL & Lin HY. Mechanisms of Anemia in CKD Jodie L. J Am Soc Nephrol.
2012. Vol 23: 16311634.
29. Suwitra K. Penyakit Ginjal Kronik. Dalam: Edisi V Jilid III Buku Ajar Ilmu Penyakit
Dalam. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FK UI. 2009.
30. Grantham J.J., Torres V.E., et al : Volume Progression in Polycystic Kidney Disease.
New England Journal Medicine ;354 : 2122-30, 2006.
31. Sukandar E. 2006. Terapi Pengganti Ginjal dengan Dialisis. Dalam: Nefrologi Klinik.
Edisi III. FK UNPAD. Hal : 536-642.
32. Kelsey MJ. British Society for Rheumatology and British Health Professionals in
Rheumatology Guideline for the Management of Gout. UK:Oxford University Press
on behalf of the British Society for Rheumatology. 2007.
33. Mc Gill N. Management of acute gout Neil McGill. Royal Prince Alfred Institute of
Rheumatology and Orthopaedics, University of Sydney, Sydney. 2004. VOL 27(1).
34. El-zawawy h & Mandell BF. Managing gout: How is it different in patients with
chronic kidney disease?. Clevelandclinic journal of medicine. 2010. vol 77(1 2).
35. Bajwa ZH. Pain management in polycystic kidney disease. Department of Anesthesia,
and Renal Division. USA: Kidney International. 2001. Vol. 60. pp. 16311644
36. Yogiantoro M. Hipertensi Essensial. Dalam: Edisi V Jilid III Buku Ajar Ilmu Penyakit
Dalam. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FK UI. 2009.
37. Chobanian, A.V., Bakris, G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jr.,
et al, 2003. The seventh report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report.
JAMA;289:2560-72.